RESUMEN
Renal cell carcinoma (RCC) accounts for approximately 3% of all adult malignancies. A third of people with RCC have metastatic lesions when diagnosed, and another third develop metachronous metastasis during follow-up or after surgical treatment. We report a case of gallbladder metastasis from clear-cell RCC in a 71-year-old woman 13 years after RCC of her right kidney. Preoperative imaging studies showed a suspicious, progressively enlarged gallbladder polyp. The patient underwent open cholecystectomy and lymph node dissection along the hepatoduodenal ligament. The pathology report was compatible with metastatic disease from the kidney that was previously resected. Gallbladder metastasis can occur from RCC several years after initial management. Physicians should be aware of this rare pathology, and intensive follow-up is essential after surgery for RCC.
Asunto(s)
Carcinoma de Células Renales/diagnóstico , Neoplasias de la Vesícula Biliar/diagnóstico , Neoplasias Renales/patología , Recurrencia Local de Neoplasia/diagnóstico , Pólipos/diagnóstico , Anciano , Carcinoma de Células Renales/secundario , Carcinoma de Células Renales/cirugía , Pancreatocolangiografía por Resonancia Magnética , Colecistectomía , Diagnóstico Diferencial , Femenino , Vesícula Biliar/diagnóstico por imagen , Vesícula Biliar/patología , Vesícula Biliar/cirugía , Neoplasias de la Vesícula Biliar/secundario , Neoplasias de la Vesícula Biliar/cirugía , Humanos , Neoplasias Renales/diagnóstico , Neoplasias Renales/cirugía , Recurrencia Local de Neoplasia/secundario , Recurrencia Local de Neoplasia/cirugía , NefrectomíaRESUMEN
The impact of HIV/AIDS on the treatment of oesophageal neoplasms remains undefined due to a lack of adequate data. We present our experience in treating patients with HIV/AIDS who have oesophageal cancer using minimally invasive techniques and discuss important key factors during perioperative management. Two men with HIV/AIDS underwent minimally invasive oesophagectomies in our department, with adequate clinical and oncological outcomes. Minimally invasive oesophagectomy can be safe and has the well-established benefits of minimally invasive techniques, offering good perioperative results and oncological outcomes in patients with HIV/AIDS. Multimodality therapy is crucial.